Ether

Ether

SCHEMBL11029157

CCOCC.NC(=O)NS(=O)(=O)c1ccccc1

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.50
LARS1 Q9P2J5 1/20 0.49
KMT2A Q03164 2/20 0.47
EGFR P00533 2/20 0.47
ERBB2 P04626 2/20 0.47
TSHR P16473 1/20 0.47
MEN1 O00255 1/20 0.46
GAA P10253 1/20 0.46
CA2 P00918 1/20 0.45
MMP2 P08253 1/20 0.44
MMP14 P50281 1/20 0.44
ALDH1A1 P00352 2/20 0.44
LMNA P02545 1/20 0.44
HTT P42858 1/20 0.44
PTGS1 P23219 1/20 0.44
PTGS2 P35354 1/20 0.44
BCAT1 P54687 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL370189 0.86 CA2 (0.56) KDM4ELARS1KMT2AEGFRERBB2
SCHEMBL5605338 0.84 CA2 (0.54) KDM4ELARS1KMT2AEGFRERBB2
SCHEMBL29176138 0.80 HTR6 (0.52) KDM4ELARS1KMT2AMEN1GAA
Ether SCHEMBL11798801 0.79 KDM4E (0.49) KDM4ELARS1KMT2AEGFRERBB2
Sulfhydryl Boron Hydride SCHEMBL11784995 0.77 GAA (0.58) KDM4EKMT2ATSHRGAAALDH1A1
SCHEMBL4700005 0.77 SMN1; SMN2 (0.57) KDM4EKMT2AEGFRERBB2TSHR
SCHEMBL29030151 0.76 BCAT1 (0.43) KDM4ELARS1KMT2AEGFRERBB2
SCHEMBL23002422 0.74 KMT2A (0.54) KDM4EKMT2AEGFRERBB2TSHR
SCHEMBL386093 0.74 KDM4E (0.57) KDM4ELARS1EGFRERBB2CA2
Diphenylmethane SCHEMBL28246450 0.74 GAA (0.56) KMT2AEGFRERBB2GAACA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0073507-B1 SULFONYL UREAS, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE HOECHST AKTIENGESELLSCHAFT (DE) 1985-10-16 EP claimed
EP-0031058-B1 SULFONYL UREAS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS HOECHST AKTIENGESELLSCHAFT (DE) 1984-04-04 EP claimed
US-4542139-A HYPOGLYCEMIC AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 1985-09-17 US disclosed
US-4379785-A Heterocyclic substituted sulfonyl ureas, and their use HOECHST AKTIENGESELLSCHAFT (DE) 1983-04-12 US disclosed
US-4379153-A Benzenesulfonyl ureas, and pharmaceutical preparations HOECHST AKTIENGESELLSCHAFT (DE) 1983-04-05 US disclosed
US-4157395-A TREATMENT OF DIABETES HOECHST AKTIENGESELLSCHAFT (DE) 1979-06-05 US disclosed
US-4132795-A Benzenesulfonyl ureas and their use for the treatment of diabetes mellitus HOECHST AKTIENGESELLSCHAFT (DE) 1979-01-02 US disclosed
US-4083979-A Thiazolidine derivatives and their use as salidiuretics HOECHST AKTIENGESELLSCHAFT (DT) 1978-04-11 US disclosed
US-4025519-A HYPOGLYCEMIC AGENTS HOECHST AKTIENGESELLSCHAFT (DT) 1977-05-24 US disclosed
US-3962244-A LOWERING OF BLOOD-SUGAR LEVELS HOECHST AKTIENGESELLSCHAFT (DT) 1976-06-08 US disclosed
US-3939269-A Benzenesulfon YL-semicarbazides for lowering blood sugar levels HOECHST AKTIENGESELLSCHAFT (DT) 1976-02-17 US disclosed
US-3932658-A Composition and method for lower blood sugar containing N-[4-(β-<2-methoxy-5-chloro-benzamido>-ethyl)-benzenesulfonyl]-N'-cyclopentyl-urea HOECHST AKTIENGESELLSCHAFT (DT) 1976-01-13 US disclosed